File Download
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-8944262831
- PMID: 8674041
- WOS: WOS:A1996UT39800011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis
Title | MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis |
---|---|
Authors | |
Issue Date | 1996 |
Citation | Cancer Research, 1996, v. 56, n. 13, p. 2922-2926 How to Cite? |
Abstract | Accelerated intestinal tumorigenesis is probable in hereditary nonpolyposis colorectal cancer, a condition associated with germ line DNA mismatch repair (MMR) gene defects, and is believed to be caused by rapid accumulation of replication errors in critical genes, such as the APC (adenomatous polyposis coli) tumor suppressor gene. To study the potential contribution of MMR genes to accelerated intestinal tumorigenesis, we crossed the Min mouse, heterozygous for a germ line mutation of Apc, with an MMR gene (Msh2)-deficient mouse. MSH2 deficiency resulted in the development of many colonic aberrant crypt foci, as well as reduced survival of the mice, secondary to both a greater number and more rapidly developing adenomas. The mechanism of inactivation of the wild-type Apc allele depended on MSH2 status. In the presence of functional MSH2, all tumors demonstrated loss of heterozygosity. In contrast, whereas all adenomas were APC negative by immunostaining, only 5 of 34 adenomas from Apc(+/-)/Msh2(-/-) mice demonstrated loss of heterozygosity of the wild-type Apc allele, suggesting that somatic Apc mutations are responsible for the additional tumors. These findings provide evidence for the important role of MMR genes in accelerated intestinal tumorigenesis, thus supporting more aggressive surveillance strategies to prevent colorectal cancer in hereditary nonpolyposis colorectal cancer. |
Persistent Identifier | http://hdl.handle.net/10722/292224 |
ISSN | 2021 Impact Factor: 13.312 2020 SCImago Journal Rankings: 4.103 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Reitmair, Armin H. | - |
dc.contributor.author | Cai, Jian Chun | - |
dc.contributor.author | Bjerknes, Matthew | - |
dc.contributor.author | Redston, Mark | - |
dc.contributor.author | Cheng, Hazel | - |
dc.contributor.author | Pind, Molly T.L. | - |
dc.contributor.author | Hay, Kazy | - |
dc.contributor.author | Mitri, Angela | - |
dc.contributor.author | Bapat, Bharati V. | - |
dc.contributor.author | Mak, Tak W. | - |
dc.contributor.author | Gallinger, Steven | - |
dc.date.accessioned | 2020-11-17T14:56:01Z | - |
dc.date.available | 2020-11-17T14:56:01Z | - |
dc.date.issued | 1996 | - |
dc.identifier.citation | Cancer Research, 1996, v. 56, n. 13, p. 2922-2926 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | http://hdl.handle.net/10722/292224 | - |
dc.description.abstract | Accelerated intestinal tumorigenesis is probable in hereditary nonpolyposis colorectal cancer, a condition associated with germ line DNA mismatch repair (MMR) gene defects, and is believed to be caused by rapid accumulation of replication errors in critical genes, such as the APC (adenomatous polyposis coli) tumor suppressor gene. To study the potential contribution of MMR genes to accelerated intestinal tumorigenesis, we crossed the Min mouse, heterozygous for a germ line mutation of Apc, with an MMR gene (Msh2)-deficient mouse. MSH2 deficiency resulted in the development of many colonic aberrant crypt foci, as well as reduced survival of the mice, secondary to both a greater number and more rapidly developing adenomas. The mechanism of inactivation of the wild-type Apc allele depended on MSH2 status. In the presence of functional MSH2, all tumors demonstrated loss of heterozygosity. In contrast, whereas all adenomas were APC negative by immunostaining, only 5 of 34 adenomas from Apc(+/-)/Msh2(-/-) mice demonstrated loss of heterozygosity of the wild-type Apc allele, suggesting that somatic Apc mutations are responsible for the additional tumors. These findings provide evidence for the important role of MMR genes in accelerated intestinal tumorigenesis, thus supporting more aggressive surveillance strategies to prevent colorectal cancer in hereditary nonpolyposis colorectal cancer. | - |
dc.language | eng | - |
dc.relation.ispartof | Cancer Research | - |
dc.title | MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.pmid | 8674041 | - |
dc.identifier.scopus | eid_2-s2.0-8944262831 | - |
dc.identifier.volume | 56 | - |
dc.identifier.issue | 13 | - |
dc.identifier.spage | 2922 | - |
dc.identifier.epage | 2926 | - |
dc.identifier.isi | WOS:A1996UT39800011 | - |
dc.identifier.issnl | 0008-5472 | - |